Clinical Trial

A First-In-Human Study of ARO-033 in Adult Participants

Name: A First-In-Human Study of ARO-033 in Adult Participants — clinical trial record (NCT07662096)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple doses of ARO-033 compared to placebo in adult normal healthy volunteers (NHVs).

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-23

Trial Details

NCT Number	NCT07662096
Lead Sponsor	Arrowhead Pharmaceuticals
Conditions	Healthy Participants
Enrollment	42 participants
Start Date	2026-06-25
Primary Completion	2027-07-18 (estimated)
Study Completion	2027-07-18 (estimated)
Updated on ClinicalTrials.gov	2026-07-22